Literature DB >> 2193308

A review of the use of saliva cotinine as a marker of tobacco smoke exposure.

R A Etzel1.   

Abstract

Cotinine, the major metabolite of nicotine, is a useful marker of exposure to tobacco smoke. It can be measured in plasma, urine, or saliva. However, distinguishing between active and passive smoking on the basis of a cotinine measurement may be difficult. In order to evaluate the relationship between saliva cotinine concentration and self-reported tobacco smoke exposure in both active and passive smokers, an English-language literature search using MEDLINE was conducted (1973-1989), and the bibliographies of identified articles were reviewed. Of 43 originally identified articles, only 22 met the criteria for inclusion. Specific information regarding population studied, reported tobacco smoke exposure, method of measurement, and cotinine concentrations was assessed. Passive smokers usually have cotinine concentrations in saliva below 5 ng/ml, but heavy passive exposure can result in levels greater than or equal to 10 ng/ml. Levels between 10 and 100 ng/ml may result from infrequent active smoking or regular active smoking with low nicotine intake. Levels greater than 100 ng/ml are probably the result of regular active smoking. Four categorizations of tobacco smoke exposure are suggested on the basis of saliva cotinine concentrations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2193308     DOI: 10.1016/0091-7435(90)90020-k

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  41 in total

1.  Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women.

Authors:  N R Boyd; R A Windsor; L L Perkins; J B Lowe
Journal:  Matern Child Health J       Date:  1998-06

Review 2.  Construct validity in health behavior research: interpreting latent variable models involving self-report and objective measures.

Authors:  Raymond F Palmer; John W Graham; Bonnie Taylor; James Tatterson
Journal:  J Behav Med       Date:  2002-12

3.  Nicotine and metabolites in meconium as evidence of maternal cigarette smoking during pregnancy and predictors of neonatal growth deficits.

Authors:  Teresa R Gray; Rina D Eiden; Kenneth E Leonard; Gerard Connors; Shannon Shisler; Marilyn A Huestis
Journal:  Nicotine Tob Res       Date:  2010-04-28       Impact factor: 4.244

Review 4.  The use of salivary biomarkers in occupational and environmental medicine.

Authors:  David Soo-Quee Koh; Gerald Choon-Huat Koh
Journal:  Occup Environ Med       Date:  2007-03       Impact factor: 4.402

Review 5.  Interpretation of oral fluid tests for drugs of abuse.

Authors:  Edward J Cone; Marilyn A Huestis
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

6.  Getting young adults to quit smoking: a formative evaluation of the X-Pack Program.

Authors:  Lorien C Abroms; Richard Windsor; Bruce Simons-Morton
Journal:  Nicotine Tob Res       Date:  2008-01       Impact factor: 4.244

7.  The challenges of translating an efficacious smoking cessation program, Commit to Quit, to the community setting of YMCAs.

Authors:  Jessica A Whiteley; David M Williams; Ernestine G Jennings; Joseph T Ciccolo; Beth C Bock; Shira Dunsiger; Bess H Marcus
Journal:  Transl Behav Med       Date:  2013-03       Impact factor: 3.046

8.  Is the hair nicotine level a more accurate biomarker of environmental tobacco smoke exposure than urine cotinine?

Authors:  W K Al-Delaimy; J Crane; A Woodward
Journal:  J Epidemiol Community Health       Date:  2002-01       Impact factor: 3.710

9.  Estimating cotinine associations and a saliva cotinine level to identify active cigarette smoking in alaska native pregnant women.

Authors:  Julia J Smith; Renee F Robinson; Burhan A Khan; Connie S Sosnoff; Denise A Dillard
Journal:  Matern Child Health J       Date:  2014-01

10.  Assessment of smoking behaviors and alcohol use in the national social life, health, and aging project.

Authors:  Melinda L Drum; Sharon Shiovitz-Ezra; Elyzabeth Gaumer; Stacy T Lindau
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-01-30       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.